Anticipated shortage
DBL CYTARABINE 2g/20mL injection vial
cytarabine · 100 mg/mL Injection, solution
- Supply impact started
- 8 Dec 2026
- Supply impact ends
- 30 June 2028
- TGA row last updated
- 4 Nov 2026
- ARTG ID
- 47286
- Sponsor
- Pfizer Australia Pty Ltd
- Sponsor phone
- 1800-675-229
- Shortage impact
- Critical
- Availability
- Available
Reason reported to TGA
Manufacturing
TGA management action
The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals.
What to do
- 1.Check your current supply — Ask your pharmacist whether you should collect a current prescription before the anticipated shortage.
- 2.Speak with your prescriber — Discuss options before supply is interrupted.
- 3.Watch the TGA report — Anticipated shortages can change before the supply impact starts.
Official sources
Last updated from the TGA Medicine Shortage Reports Database (report generated 12 November 2026 10:24:39 PM).
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.